Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis.
Tadahiro Kumagai, Takeshi Sato, Shunji Natsuka, Yukito Kobayashi, Dapeng Zhou, Tadashi Shinkai, Satoru Hayakawa, Kiyoshi Furukawa
Index: Glycoconj. J. 27(7-9) , 685-95, (2010)
Full Text: HTML
Abstract
Human β-1,4-galactosyltransferase (β-1,4-GalT) V was shown to be involved in the biosynthesis of N-glycans, O-glycans and lactosylceramide (Lac-Cer) by in vitro studies. To determine its substrate specificity, enzymatic activity and its products were analyzed using mouse embryonic fibroblast (MEF) cells from β-1,4-GalT V (B4galt5)-mutant mice. Analysis of expression levels of the β-1,4-GalT I-VI genes revealed that the expression of the β-1,4-GalT V gene in B4galt5 ( +/- ) - and B4galt5 ( -/- ) -derived MEF cells are a half and null when compared to that of B4galt5 ( +/+ )-derived MEF cells without altering the expression levels of other β-1,4-GalT genes. These MEF cells showed no apparent difference in their growth. When β-1,4-GalT activities were determined towards GlcNAcβ-S-pNP, no significant difference in its specific activity was obtained among B4galt5 ( +/+ )-, B4galt5 ( +/- ) - and B4galt5 ( -/- ) -derived MEF cells. No significant differences were obtained in structures and amounts of N-glycans and lectin bindings to membrane glycoproteins among B4galt5 ( +/+ )-, B4galt5 ( +/- ) - and B4galt5 ( -/- ) -derived MEF cells. However, when cell homogenates were incubated with glucosylceramide in the presence of UDP-[(3)H]Gal, Lac-Cer synthase activity in B4galt5 ( +/- ) - and B4galt5 ( -/- ) -derived MEF cells decreased to 41% and 11% of that of B4galt5 ( +/+ )-derived MEF cells. Consistent with this, amounts of Lac-Cer and its derivative GM3 in B4galt5 ( -/- ) -derived MEF cells decreased remarkably when compared with those of B4galt5 ( +/+ )-derived MEF cells. These results indicate that murine β-1,4-GalT V is involved in Lac-Cer biosynthesis.
Related Compounds
Related Articles:
2012-02-01
[Infect. Immun. 80(2) , 506-17, (2012)]
2011-04-01
[Oncol. Rep. 25(4) , 1161-7, (2011)]
2009-06-01
[Glycobiology 19(6) , 576-82, (2009)]
2012-10-01
[Innate Immunity 18(5) , 709-16, (2012)]
2012-06-01
[Colloids Surf. B Biointerfaces 94 , 374-7, (2012)]